Viveve Medical, Inc.
VIVE · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $115,023 | $73,956 | $48,287 | $326,120 |
| - Cash | $19 | $7 | $13 | $30 |
| + Debt | $5 | $6 | $4 | $31 |
| Enterprise Value | $115,009 | $73,955 | $48,278 | $326,121 |
| Revenue | $6 | $5 | $7 | $19 |
| % Growth | 17.3% | -16.6% | -64.5% | – |
| Gross Profit | $1 | $0 | $1 | $7 |
| % Margin | 9.6% | 5.4% | 15.5% | 39.5% |
| EBITDA | -$20 | -$19 | -$31 | -$44 |
| % Margin | -305.5% | -352.7% | -467.2% | -238.5% |
| Net Income | -$22 | -$22 | -$43 | -$49 |
| % Margin | -342.8% | -400% | -647.6% | -265.6% |
| EPS Diluted | -2.65 | -16.56 | -121.91 | -1,583.5 |
| % Growth | 84% | 86.4% | 92.3% | – |
| Operating Cash Flow | -$13 | -$15 | -$31 | -$43 |
| Capital Expenditures | -$0 | -$1 | -$1 | -$2 |
| Free Cash Flow | -$13 | -$16 | -$32 | -$45 |